{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:34:31Z","timestamp":1790760871963,"version":"4.1.0"},"reference-count":97,"publisher":"Baishideng Publishing Group Inc.","issue":"41","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.5129","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T02:51:58Z","timestamp":1257389518000},"page":"5129","source":"Crossref","is-referenced-by-count":19,"title":["Costimulatory molecule programmed death-1 in the cytotoxic response during chronic hepatitis C"],"prefix":"10.3748","volume":"15","author":[{"given":"Juan Ram\u00f3n","family":"Larrubia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selma","family":"Benito-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaqu\u00edn","family":"Miquel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miryam","family":"Calvino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Sanz-de-Villalobos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinidad","family":"Parra-Cid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.","DOI":"10.1056\/NEJM200107053450107"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Bowen DG, Walker CM. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 2005;436:946-952.","DOI":"10.1038\/nature04079"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Liang TJ, Heller T. Pathogenesis of hepatitis C-associated hepatocellular carcinoma. Gastroenterology 2004;127:S62-S71.","DOI":"10.1053\/j.gastro.2004.09.017"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Afdhal NH. The natural history of hepatitis C. Semin Liver Dis 2004;24 Suppl 2:3-8.","DOI":"10.1055\/s-2004-832922"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gon&ccedil;ales FL Jr, H&auml;ussinger D, Diago M, Carosi G, Dhumeaux D. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982.","DOI":"10.1056\/NEJMoa020047"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-965.","DOI":"10.1016\/S0140-6736(01)06102-5"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Hayashi N, Takehara T. Antiviral therapy for chronic hepatitis C: past, present, and future. J Gastroenterol 2006;41:17-27.","DOI":"10.1007\/s00535-005-1740-7"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Gr&uuml;ner NH, Gerlach TJ, Jung MC, Diepolder HM, Schirren CA, Schraut WW, Hoffmann R, Zachoval R, Santantonio T, Cucchiarini M. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C. J Infect Dis 2000;181:1528-1536.","DOI":"10.1086\/315450"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, Roggendorf M, von Weizs&auml;cker F, Blum HE, Thimme R. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 2005;42:828-837.","DOI":"10.1002\/hep.20856"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Gruener NH, Lechner F, Jung MC, Diepolder H, Gerlach T, Lauer G, Walker B, Sullivan J, Phillips R, Pape GR. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 2001;75:5550-5558.","DOI":"10.1128\/JVI.75.12.5550-5558.2001"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Mueller DL, Jenkins MK, Schwartz RH. Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 1989;7:445-480.","DOI":"10.1146\/annurev.iy.07.040189.002305"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Bretscher P. The two-signal model of lymphocyte activation twenty-one years later. Immunol Today 1992;13:74-76.","DOI":"10.1016\/0167-5699(92)90138-W"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Nurieva R, Thomas S, Nguyen T, Martin-Orozco N, Wang Y, Kaja MK, Yu XZ, Dong C. T-cell tolerance or function is determined by combinatorial costimulatory signals. EMBO J 2006;25:2623-2633.","DOI":"10.1038\/sj.emboj.7601146"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Frauwirth KA, Thompson CB. Activation and inhibition of lymphocytes by costimulation. J Clin Invest 2002;109:295-299.","DOI":"10.1172\/JCI0214941"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Carter L, Fouser LA, Jussif J, Fitz L, Deng B, Wood CR, Collins M, Honjo T, Freeman GJ, Carreno BM. PD-1:PD-L inhibitory pathway affects both CD4(+) and CD8(+) T cells and is overcome by IL-2. Eur J Immunol 2002;32:634-643.","DOI":"10.1002\/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001;2:261-268.","DOI":"10.1038\/85330"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999;11:141-151.","DOI":"10.1016\/S1074-7613(00)80089-8"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001;291:319-322.","DOI":"10.1126\/science.291.5502.319"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006;439:682-687.","DOI":"10.1038\/nature04444"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Agata Y, Kawasaki A, Nishimura H, Ishida Y, Tsubata T, Yagita H, Honjo T. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol 1996;8:765-772.","DOI":"10.1093\/intimm\/8.5.765"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Zhang X, Schwartz JC, Guo X, Bhatia S, Cao E, Lorenz M, Cammer M, Chen L, Zhang ZY, Edidin MA. Structural and functional analysis of the costimulatory receptor programmed death-1. Immunity 2004;20:337-347.","DOI":"10.1016\/S1074-7613(04)00051-2"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Grakoui A, John Wherry E, Hanson HL, Walker C, Ahmed R. Turning on the off switch: regulation of anti-viral T cell responses in the liver by the PD-1\/PD-L1 pathway. J Hepatol 2006;45:468-472.","DOI":"10.1016\/j.jhep.2006.07.009"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Okazaki T, Honjo T. The PD-1-PD-L pathway in immunological tolerance. Trends Immunol 2006;27:195-201.","DOI":"10.1016\/j.it.2006.02.001"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Okazaki T, Maeda A, Nishimura H, Kurosaki T, Honjo T. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA 2001;98:13866-13871.","DOI":"10.1073\/pnas.231486598"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Chemnitz JM, Parry RV, Nichols KE, June CH, Riley JL. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 2004;173:945-954.","DOI":"10.4049\/jimmunol.173.2.945"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Ishida M, Iwai Y, Tanaka Y, Okazaki T, Freeman GJ, Minato N, Honjo T. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. Immunol Lett 2002;84:57-62.","DOI":"10.1016\/S0165-2478(02)00142-6"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Yamazaki T, Akiba H, Iwai H, Matsuda H, Aoki M, Tanno Y, Shin T, Tsuchiya H, Pardoll DM, Okumura K. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002;169:5538-5545.","DOI":"10.4049\/jimmunol.169.10.5538"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Liang SC, Latchman YE, Buhlmann JE, Tomczak MF, Horwitz BH, Freeman GJ, Sharpe AH. Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses. Eur J Immunol 2003;33:2706-2716.","DOI":"10.1002\/eji.200324228"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Wiendl H, Mitsdoerffer M, Schneider D, Chen L, Lochm&uuml;ller H, Melms A, Weller M. Human muscle cells express a B7-related molecule, B7-H1, with strong negative immune regulatory potential: a novel mechanism of counterbalancing the immune attack in idiopathic inflammatory myopathies. FASEB J 2003;17:1892-1894.","DOI":"10.1096\/fj.03-0039fje"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Salama AD, Chitnis T, Imitola J, Ansari MJ, Akiba H, Tushima F, Azuma M, Yagita H, Sayegh MH, Khoury SJ. Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis. J Exp Med 2003;198:71-78.","DOI":"10.1084\/jem.20022119"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"M&uuml;hlbauer M, Fleck M, Sch&uuml;tz C, Weiss T, Froh M, Blank C, Sch&ouml;lmerich J, Hellerbrand C. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol 2006;45:520-528.","DOI":"10.1016\/j.jhep.2006.05.007"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Maier H, Isogawa M, Freeman GJ, Chisari FV. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8+ T lymphocytes in the liver. J Immunol 2007;178:2714-2720.","DOI":"10.4049\/jimmunol.178.5.2714"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Meier A, Bagchi A, Sidhu HK, Alter G, Suscovich TJ, Kavanagh DG, Streeck H, Brockman MA, LeGall S, Hellman J. Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands. AIDS 2008;22:655-658.","DOI":"10.1097\/QAD.0b013e3282f4de23"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Willberg C, Barnes E, Klenerman P. HCV immunology--death and the maiden T cell. Cell Death Differ 2003;10 Suppl 1:S39-S47.","DOI":"10.1038\/sj.cdd.4401122"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Bartenschlager R, Lohmann V. Replication of hepatitis C virus. J Gen Virol 2000;81:1631-1648.","DOI":"10.1099\/0022-1317-81-7-1631"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Knolle PA, Gerken G. Local control of the immune response in the liver. Immunol Rev 2000;174:21-34.","DOI":"10.1034\/j.1600-0528.2002.017408.x"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Knolle PA, Limmer A. Neighborhood politics: the immunoregulatory function of organ-resident liver endothelial cells. Trends Immunol 2001;22:432-437.","DOI":"10.1016\/S1471-4906(01)01957-3"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3:51-62.","DOI":"10.1038\/nri981"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995;270:1189-1192.","DOI":"10.1126\/science.270.5239.1189"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Isogawa M, Furuichi Y, Chisari FV. Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Immunity 2005;23:53-63.","DOI":"10.1016\/j.immuni.2005.05.005"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Nakamoto N, Kaplan DE, Coleclough J, Li Y, Valiga ME, Kaminski M, Shaked A, Olthoff K, Gostick E, Price DA. Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization. Gastroenterology 2008;134:1927-1937, 1937.e1-e2.","DOI":"10.1053\/j.gastro.2008.02.033"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Iwai Y, Terawaki S, Ikegawa M, Okazaki T, Honjo T. PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 2003;198:39-50.","DOI":"10.1084\/jem.20022235"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000;192:1027-1034.","DOI":"10.1084\/jem.192.7.1027"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Dong H, Zhu G, Tamada K, Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999;5:1365-1369.","DOI":"10.1038\/70932"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses. Science 1996;272:74-79.","DOI":"10.1126\/science.272.5258.74"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Boettler T, Spangenberg HC, Neumann-Haefelin C, Panther E, Urbani S, Ferrari C, Blum HE, von Weizs&auml;cker F, Thimme R. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 2005;79:7860-7867.","DOI":"10.1128\/JVI.79.12.7860-7867.2005"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Cabrera R, Tu Z, Xu Y, Firpi RJ, Rosen HR, Liu C, Nelson DR. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 2004;40:1062-1071.","DOI":"10.1002\/hep.20454"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Rushbrook SM, Ward SM, Unitt E, Vowler SL, Lucas M, Klenerman P, Alexander GJ. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 2005;79:7852-7859.","DOI":"10.1128\/JVI.79.12.7852-7859.2005"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Gavin MA, Clarke SR, Negrou E, Gallegos A, Rudensky A. Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat Immunol 2002;3:33-41.","DOI":"10.1038\/ni743"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Raimondi G, Shufesky WJ, Tokita D, Morelli AE, Thomson AW. Regulated compartmentalization of programmed cell death-1 discriminates CD4+CD25+ resting regulatory T cells from activated T cells. J Immunol 2006;176:2808-2816.","DOI":"10.4049\/jimmunol.176.5.2808"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"Polanczyk MJ, Hopke C, Vandenbark AA, Offner H. Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). Int Immunol 2007;19:337-343.","DOI":"10.1093\/intimm\/dxl151"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Franceschini D, Paroli M, Francavilla V, Videtta M, Morrone S, Labbadia G, Cerino A, Mondelli MU, Barnaba V. PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J Clin Invest 2009;119:551-564.","DOI":"10.1172\/JCI36604"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"Kasprowicz V, Schulze Zur Wiesch J, Kuntzen T, Nolan BE, Longworth S, Berical A, Blum J, McMahon C, Reyor LL, Elias N. High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome. J Virol 2008;82:3154-3160.","DOI":"10.1128\/JVI.02474-07"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Golden-Mason L, Palmer B, Klarquist J, Mengshol JA, Castelblanco N, Rosen HR. Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 2007;81:9249-9258.","DOI":"10.1128\/JVI.00409-07"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M, Hanson HL, Steinberg JP, Masopust D, Wherry EJ. Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 2007;81:2545-2553.","DOI":"10.1128\/JVI.02021-06"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Golden-Mason L, Klarquist J, Wahed AS, Rosen HR. Cutting edge: programmed death-1 expression is increased on immunocytes in chronic hepatitis C virus and predicts failure of response to antiviral therapy: race-dependent differences. J Immunol 2008;180:3637-3641.","DOI":"10.4049\/jimmunol.180.6.3637"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Zhang Z, Jin B, Zhang JY, Xu B, Wang H, Shi M, Wherry EJ, Lau GK, Wang FS. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients. J Hepatol 2009;50:1163-1173.","DOI":"10.1016\/j.jhep.2009.01.026"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Ye P, Weng ZH, Zhang SL, Zhang JA, Zhao L, Dong JH, Jie SH, Pang R, Wei RH. Programmed death-1 expression is associated with the disease status in hepatitis B virus infection. World J Gastroenterol 2008;14:4551-4557.","DOI":"10.3748\/wjg.14.4551"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 2008;45:963-970.","DOI":"10.1016\/j.molimm.2007.07.038"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS. Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat Med 2006;12:1198-1202.","DOI":"10.1038\/nm1482"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006;443:350-354.","DOI":"10.1038\/nature05115"},{"key":"ref62","unstructured":"Li YG, Chen LE, Chen GF, Wang FS. [Expressions and significance of B7-H1 and programmed death-1 in lymphocytes from patients with chronic hepatitis B virus infection]. Zhonghua Ganzangbing Zazhi 2007;15:738-741."},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Penna A, Pilli M, Zerbini A, Orlandini A, Mezzadri S, Sacchelli L, Missale G, Ferrari C. Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection. Hepatology 2007;45:588-601.","DOI":"10.1002\/hep.21541"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Boni C, Fisicaro P, Valdatta C, Amadei B, Di Vincenzo P, Giuberti T, Laccabue D, Zerbini A, Cavalli A, Missale G. Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 2007;81:4215-4225.","DOI":"10.1128\/JVI.02844-06"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Rutebemberwa A, Ray SC, Astemborski J, Levine J, Liu L, Dowd KA, Clute S, Wang C, Korman A, Sette A. High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection. J Immunol 2008;181:8215-8225.","DOI":"10.4049\/jimmunol.181.12.8215"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, Ferrari C. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006;80:11398-11403.","DOI":"10.1128\/JVI.01177-06"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"Boettler T, Panther E, Bengsch B, Nazarova N, Spangenberg HC, Blum HE, Thimme R. Expression of the interleukin-7 receptor alpha chain (CD127) on virus-specific CD8+ T cells identifies functionally and phenotypically defined memory T cells during acute resolving hepatitis B virus infection. J Virol 2006;80:3532-3540.","DOI":"10.1128\/JVI.80.7.3532-3540.2006"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Bengsch B, Spangenberg HC, Kersting N, Neumann-Haefelin C, Panther E, von Weizs&auml;cker F, Blum HE, Pircher H, Thimme R. Analysis of CD127 and KLRG1 expression on hepatitis C virus-specific CD8+ T cells reveals the existence of different memory T-cell subsets in the peripheral blood and liver. J Virol 2007;81:945-953.","DOI":"10.1128\/JVI.01354-06"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Radziewicz H, Ibegbu CC, Hon H, Osborn MK, Obideen K, Wehbi M, Freeman GJ, Lennox JL, Workowski KA, Hanson HL. Impaired hepatitis C virus (HCV)-specific effector CD8+ T cells undergo massive apoptosis in the peripheral blood during acute HCV infection and in the liver during the chronic phase of infection. J Virol 2008;82:9808-9822.","DOI":"10.1128\/JVI.01075-08"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B. Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection. J Immunol 2002;169:3447-3458.","DOI":"10.4049\/jimmunol.169.6.3447"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"Folgori A, Spada E, Pezzanera M, Ruggeri L, Mele A, Garbuglia AR, Perrone MP, Del Porto P, Piccolella E, Cortese R. Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance. Gut 2006;55:1012-1019.","DOI":"10.1136\/gut.2005.080077"},{"key":"ref72","doi-asserted-by":"crossref","unstructured":"Keir ME, Francisco LM, Sharpe AH. PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 2007;19:309-314.","DOI":"10.1016\/j.coi.2007.04.012"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Yao S, Chen L. Reviving exhausted T lymphocytes during chronic virus infection by B7-H1 blockade. Trends Mol Med 2006;12:244-246.","DOI":"10.1016\/j.molmed.2006.04.007"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Jeong HY, Lee YJ, Seo SK, Lee SW, Park SJ, Lee JN, Sohn HS, Yao S, Chen L, Choi I. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection. J Leukoc Biol 2008;83:755-764.","DOI":"10.1189\/jlb.0307168"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Nakamoto N, Cho H, Shaked A, Olthoff K, Valiga ME, Kaminski M, Gostick E, Price DA, Freeman GJ, Wherry EJ. Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1\/CTLA-4 blockade. PLoS Pathog 2009;5:e1000313.","DOI":"10.1371\/journal.ppat.1000313"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Arribillaga L, Sarobe P, Arina A, Gorraiz M, Borr&aacute;s-Cuesta F, Ruiz J, Prieto J, Chen L, Melero I, Lasarte JJ. Enhancement of CD4 and CD8 immunity by anti-CD137 (4-1BB) monoclonal antibodies during hepatitis C vaccination with recombinant adenovirus. Vaccine 2005;23:3493-3499.","DOI":"10.1016\/j.vaccine.2005.02.003"},{"key":"ref77","doi-asserted-by":"crossref","unstructured":"Zabaleta A, Arribillaga L, Llopiz D, Dotor J, Lasarte JJ, Prieto J, Borr&aacute;s-Cuesta F, Esteban JI, Quer J, Vayreda F. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40. Antiviral Res 2007;74:25-35.","DOI":"10.1016\/j.antiviral.2007.01.001"},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"Nanji SA, Hancock WW, Anderson CC, Adams AB, Luo B, Schur CD, Pawlick RL, Wang L, Coyle AJ, Larsen CP. Multiple combination therapies involving blockade of ICOS\/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant 2004;4:526-536.","DOI":"10.1111\/j.1600-6143.2004.00384.x"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Blackburn SD, Shin H, Haining WN, Zou T, Workman CJ, Polley A, Betts MR, Freeman GJ, Vignali DA, Wherry EJ. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat Immunol 2009;10:29-37.","DOI":"10.1038\/ni.1679"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Golden-Mason L, Palmer BE, Kassam N, Townshend-Bulson L, Livingston S, McMahon BJ, Castelblanco N, Kuchroo V, Gretch DR, Rosen HR. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J Virol 2009;83:9122-9130.","DOI":"10.1128\/JVI.00639-09"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Lopes AR, Kellam P, Das A, Dunn C, Kwan A, Turner J, Peppa D, Gilson RJ, Gehring A, Bertoletti A. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest 2008;118:1835-1845.","DOI":"10.1172\/JCI33402"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Kittlesen DJ, Chianese-Bullock KA, Yao ZQ, Braciale TJ, Hahn YS. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. J Clin Invest 2000;106:1239-1249.","DOI":"10.1172\/JCI10323"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Sundstr&ouml;m S, Ota S, Dimberg LY, Masucci MG, Bergqvist A. Hepatitis C virus core protein induces an anergic state characterized by decreased interleukin-2 production and perturbation of mitogen-activated protein kinase responses. J Virol 2005;79:2230-2239.","DOI":"10.1128\/JVI.79.4.2230-2239.2005"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Yao ZQ, King E, Prayther D, Yin D, Moorman J. T cell dysfunction by hepatitis C virus core protein involves PD-1\/PDL-1 signaling. Viral Immunol 2007;20:276-287.","DOI":"10.1089\/vim.2006.0096"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Lukens JR, Cruise MW, Lassen MG, Hahn YS. Blockade of PD-1\/B7-H1 interaction restores effector CD8+ T cell responses in a hepatitis C virus core murine model. J Immunol 2008;180:4875-4884.","DOI":"10.4049\/jimmunol.180.7.4875"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Maillard P, Krawczynski K, Nitkiewicz J, Bronnert C, Sidorkiewicz M, Gounon P, Dubuisson J, Faure G, Crainic R, Budkowska A. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 2001;75:8240-8250.","DOI":"10.1128\/JVI.75.17.8240-8250.2001"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Masalova OV, Atanadze SN, Samokhvalov EI, Petrakova NV, Kalinina TI, Smirnov VD, Khudyakov YE, Fields HA, Kushch AA. Detection of hepatitis C virus core protein circulating within different virus particle populations. J Med Virol 1998;55:1-6.","DOI":"10.1002\/(SICI)1096-9071(199805)55:1<1::AID-JMV1>3.0.CO;2-7"},{"key":"ref88","unstructured":"Xu B, Zhang Z, Shi Y, Chen XY, Wang FS. [PD-1 up-regulation influenced apoptosis of HBV-specific CD8 T cells in patients with acute resolved hepatitis B]. Zhonghua Yixue Zazhi 2009;89:1158-1161."},{"key":"ref89","doi-asserted-by":"crossref","unstructured":"Boasso A, Hardy AW, Landay AL, Martinson JL, Anderson SA, Dolan MJ, Clerici M, Shearer GM. PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin Immunol 2008;129:132-144.","DOI":"10.1016\/j.clim.2008.05.009"},{"key":"ref90","unstructured":"Iglesias-Chiesa MC, Crabtree-Ram&iacute;rez B, Reyes-Ter&aacute;n G. [A new therapeutic strategy to control HIV? The PD1 molecule and its role in inhibiting cellular immune responses]. Gac Med Mex 2008;144:75-78."},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Trautmann L, Chomont N, S&eacute;kaly RP. [Inhibition of the PD-1 pathway restores the effector function of HIV-specific T cells]. Med Sci (Paris) 2007;23:24-25.","DOI":"10.1051\/medsci\/200723124"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Urbani S, Amadei B, Tola D, Pedrazzi G, Sacchelli L, Cavallo MC, Orlandini A, Missale G, Ferrari C. Restoration of HCV-specific T cell functions by PD-1\/PD-L1 blockade in HCV infection: effect of viremia levels and antiviral treatment. J Hepatol 2008;48:548-558.","DOI":"10.1016\/j.jhep.2007.12.014"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"von Herrath MG, Berger DP, Homann D, Tishon T, Sette A, Oldstone MB. Vaccination to treat persistent viral infection. Virology 2000;268:411-419.","DOI":"10.1006\/viro.1999.0130"},{"key":"ref94","doi-asserted-by":"crossref","unstructured":"Dikici B, Kalayci AG, Ozgenc F, Bosnak M, Davutoglu M, Ece A, Ozkan T, Ozeke T, Yagci RV, Haspolat K. Therapeutic vaccination in the immunotolerant phase of children with chronic hepatitis B infection. Pediatr Infect Dis J 2003;22:345-349.","DOI":"10.1097\/01.inf.0000059443.49414.8b"},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Ha SJ, Mueller SN, Wherry EJ, Barber DL, Aubert RD, Sharpe AH, Freeman GJ, Ahmed R. Enhancing therapeutic vaccination by blocking PD-1-mediated inhibitory signals during chronic infection. J Exp Med 2008;205:543-555.","DOI":"10.1084\/jem.20071949"},{"key":"ref96","doi-asserted-by":"crossref","unstructured":"Velu V, Titanji K, Zhu B, Husain S, Pladevega A, Lai L, Vanderford TH, Chennareddi L, Silvestri G, Freeman GJ. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 2009;458:206-210.","DOI":"10.1038\/nature07662"},{"key":"ref97","doi-asserted-by":"crossref","unstructured":"Finnefrock AC, Tang A, Li F, Freed DC, Feng M, Cox KS, Sykes KJ, Guare JP, Miller MD, Olsen DB. PD-1 blockade in rhesus macaques: impact on chronic infection and prophylactic vaccination. J Immunol 2009;182:980-987.","DOI":"10.4049\/jimmunol.182.2.980"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i41\/5129.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:18:26Z","timestamp":1558628306000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i41\/5129.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":97,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.5129","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}